CAS No – 1360460-82-7

Status – Pre-Validation

Product Description

Anlotinib is a multi-targeted oral tyrosine kinase inhibitor used in cancer treatment. It primarily inhibits vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptors (PDGFR), fibroblast growth factor receptors (FGFR), and c-Kit. It is designed to suppress tumor angiogenesis and proliferation by blocking these receptors.